My bookmarksSign up free

Commission Implementing Regulation (EU) 2025/2526 of 16 December 2025 amending Implementing Regulation (EU) 2023/2713 to correct the designation of an EU reference laboratory and to designate European Union reference laboratories for in vitro diagnostic medical devices intended for detection or quantification of markers of parasite infection and detection of blood grouping markers

Commission Implementing Regulation (EU) 2025/2526 of 16 December 2025 amending Implementing Regulation (EU) 2023/2713 to correct the designation of an EU reference laboratory and to designate European Union reference laboratories for in vitro diagnostic medical devices intended for detection or quantification of markers of parasite infection and detection of blood grouping markers

Implementing Regulation (EU) 2025/2526 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The Annex to Implementing Regulation (EU) 2023/2713 is amended in accordance with the Annex to this Regulation.

Article 2

1.   This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union . 2.   For the purpose of the tasks referred to in Article 100(2) of Regulation (EU) 2017/746, point 3 of the Annex to this Regulation shall apply from 1 May 2026. 3.   Without prejudice to paragraph 2 of this Article, the EU reference laboratories designated in point 3 of the Annex to this Regulation shall carry out the task referred to in Article 100(2), point (a), of Regulation (EU) 2017/746, only for devices for which manufacturers or authorised representatives lodge formal applications for conformity assessment with a notified body in accordance with Section 4.3, first subparagraph, of Annex VII to Regulation (EU) 2017/746 from 1 May 2026.

Supplementary provisions

ANNEXSupplementary provisions

ANNEX The Annex to Implementing Regulation (EU) 2023/2713 is amended as follows: (1) point 2(a) is replaced by the following: ‘(a) Consortium managed by: Servicio Madrileño de Salud (SERMAS), Paseo de la Castellana 280, 28046, Madrid, Spain and composed of Hospital General Universitario Gregorio Marañón and Fundación para la Investigación Biomédica del Hospital Gregorio Marañón, C/Doctor Esquerdo n°46, 28007, Madrid, Spain, Hospital Universitario la Paz, Paseo de la Castellana 261, 28046, Madrid, Spain, and Hospital Universitario Ramón y Cajal, Carretera de Colmenar Viejo Km 9,100, 28034, Madrid, Spain;’; (2) point 3(a) is replaced by the following: ‘(a) Consortium managed by: Servicio Madrileño de Salud (SERMAS), Paseo de la Castellana 280, 28046, Madrid, Spain and composed of Hospital General Universitario Gregorio Marañón and Fundación para la Investigación Biomédica del Hospital Gregorio Marañón, C/Doctor Esquerdo n°46, 28007, Madrid, Spain, Hospital Universitario la Paz, Paseo de la Castellana 261, 28046, Madrid, Spain, and Hospital Universitario Ramón y Cajal, Carretera de Colmenar Viejo Km 9,100, 28034, Madrid, Spain;’; (3) the following points 5 and 6 are added: ‘5. EU reference laboratories for devices intended for detection or quantification of markers of parasite infection: (a) Instituto de Salud Carlos III, Carretera de Majadahonda – Pozuelo, Km. 2,200, 28220, Majadahonda, Madrid, Spain; (b) Consulting Químico Sanitario SLU, Calle Marie Curie 7, 28521, Rivas-Vaciamadrid, Madrid, Spain. 6. EU reference laboratories for devices intended for detection of blood grouping markers: (a) EU Referenzlabor für In-vitro-Diagnostika am Paul-Ehrlich-Institut, Paul-Ehrlich-Straße 51–59, 63225, Langen, Germany; (b) Consulting Químico Sanitario SLU, Calle Marie Curie 7, 28521, Rivas-Vaciamadrid, Madrid, Spain; (c) RISE Research Institutes of Sweden AB, Brinellgatan 4, 504 62, Borås, Sweden.’.

Other acts of the same type
Commission Implementing Regulation (EU) 2024/749 of 29 February 2024 concerning the authorisation of lignosulphonate as a feed additive for all animal speciesCommission Implementing Regulation (EU) 2024/750 of 29 February 2024 concerning the renewal of the authorisation of thaumatin as a feed additive for all animal species and repealing Implementing Regulation (EU) No 869/2012Commission Implementing Regulation (EU) 2024/752 of 29 February 2024 concerning the denial of authorisation of a preparation of astaxanthin-rich Phaffia rhodozyma (ATCC SD-5340) as a feed additive for salmon and troutCommission Implementing Regulation (EU) 2024/754 of 29 February 2024 amending Implementing Regulation (EU) 2020/1762 as regards the terms of the authorisation of a preparation of Bacillus subtilis DSM 32324, Bacillus subtilis DSM 32325 and Bacillus amyloliquefaciens DSM 25840 as a feed additive for all poultry species for fattening or reared for laying or reared for breeding (holder of authorisation: Chr. Hansen A/S)Commission Implementing Regulation (EU) 2024/755 of 29 February 2024 on extending the derogation from Council Regulation (EC) No 1967/2006 as regards the minimum distance from the coast and the minimum sea depth for boat seines fishing for transparent and Ferrer’s gobies (Aphia minuta and Pseudaphia ferreri) and Lowbody picarel (Spicara smaris) in certain territorial waters of Spain (Balearic Islands)Commission Implementing Regulation (EU) 2024/763 of 29 February 2024 concerning the renewal of the authorisation of preparations of Lactiplantibacillus plantarum NCIMB 30083 and Lactiplantibacillus plantarum NCIMB 30084 as feed additives for all animal species and repealing Implementing Regulation (EU) No 308/2013Commission Implementing Regulation (EU) 2024/764 of 29 February 2024 concerning the authorisation of a preparation of Bacillus subtilis CNCM I-4606, CNCM I-5043 and CNCM I-4607 and Lactococcus lactis CNCM I-4609 as a feed additive for all animal speciesCouncil Regulation (EU, Euratom) 2024/765 of 29 February 2024 amending Regulation (EU, Euratom) 2020/2093 laying down the multiannual financial framework for the years 2021 to 2027Commission Implementing Regulation (EU) 2024/771 of 29 February 2024 amending Regulation (EC) No 152/2009 laying down the methods of sampling and analysis for the official control of feedRegulation (EU) 2024/792 of the European Parliament and of the Council of 29 February 2024 establishing the Ukraine FacilityRegulation (EU) 2024/795 of the European Parliament and of the Council of 29 February 2024 establishing the Strategic Technologies for Europe Platform (STEP), and amending Directive 2003/87/EC and Regulations (EU) 2021/1058, (EU) 2021/1056, (EU) 2021/1057, (EU) No 1303/2013, (EU) No 223/2014, (EU) 2021/1060, (EU) 2021/523, (EU) 2021/695, (EU) 2021/697 and (EU) 2021/241Commission Implementing Regulation (EU) 2024/808 of 29 February 2024 amending Annexes I and II to Implementing Regulation (EU) 2023/594 laying down special control measures for African swine fever

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next